Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Publication year range
1.
Rev. Assoc. Med. Bras. (1992, Impr.) ; 43(2): 93-8, abr.-jun. 1997. tab, graf
Article in Portuguese | LILACS | ID: lil-197139

ABSTRACT

A infusao de células hematopoéticas totipotentes criopreservadas permite a recuperaçao da hematopoese após quimioterapia mieolblativa. Objetivo. A formaçao de cristais de gelo durante o processo de congelamento é o fator principal que causa ruptura das estruturas celulares. A criopreservaçao dessas células a uma taxa constante preveniria os danos causados pelo congelamento brusco. Métodos. Vinte e três pacientes com mediana de 25 anos (variaçao 3-57) tiveram a medula óssea e/ou células-tronco periféricas (CTP) coletadas no período de março de 1993 a outubro de 1994, totalizando 86 congelamentos. Os pacientes apresentavam as seguintes neoplasias: linfoma nao-Hodgkin (n=5), leucemia mielóide aguda (n=8), leucemia linfóide aguda (n=6), doença de Hodkin (n=3) e mieloma múltiplo (n=1). O congelamento foicontrolado por um computador, acoplado ao sistema, às seguintes temperaturas: -1 graus Celsius/min até -45 graus Celsius e depois a -10 graus Celsius/min até -80 graus Celsius. Após o congelamento, as células foram mantidas em freezer a -110 graus Celsius até o momento da infusao. Para obtençao das CTP, empregou-se o fator de crescimento estimulante de granulócitos (G-CSF). Resultados. Uma mediana de 3,16 x 10(8) céls./kg (variaçao 0,86-24,22) de CTP e 2,03 x 10(8) céls./kg (variaçao 0,19-12,21) de medula óssea foi congelada. A mediana para atingir granulócitos maior ou igual a 500/muL e plaquetas maior que 20.000/muL foi de 12 dias (variaçao 8-40) e 31 dias (variaçao 8-80), respectivamente. Todos os pacientes tiveram recuperaçao hematopoética após a infusao das células criopreservadas. Conclusao. A criopreservaçao em congelador program vel permite o armazenamento de células hematopoéticas e, potencialmente, pode causar menor dano celular.


Subject(s)
Female , Humans , Child, Preschool , Middle Aged , Adult , Adolescent , Child , Stem Cells , Bone Marrow , Cryopreservation/methods , Transplantation, Autologous/methods , Freezing , Hematopoiesis , Neoplasms/drug therapy , Antineoplastic Agents/therapeutic use
2.
Rev Assoc Med Bras (1992) ; 43(2): 93-8, 1997.
Article in Portuguese | MEDLINE | ID: mdl-9336042

ABSTRACT

UNLABELLED: The cryopreservation of hematopoietic stem cells can be used for rescuing the hematopoiesis after high dose chemotherapy. PURPOSE: The ice crystal formation during the freezing procedure is the key point that can be harmful to the cells. The cryopreservation of hematopoietic stem cells in a controlled-rate freezer could decrease the cell damage. METHODS: Twenty-three patients with a median age of 26 years (range 03-57) had bone marrow and/or peripheral blood stem cells harvested from March 1993 through October 1994, ending up to 86 freezing procedures. The patient's diagnoses are as follows: Non-Hodgkin's Lymphoma (n = 5); Acute Myelogenous Leukemia (n = 8); Acute Lymphocytic Leukemia (n = 6); Hodgkin's disease (n = 3); Multiple Myeloma (n = 1). The cells were frozen away in a controlled-rate freezer chamber at the following rate: -1 degree C/min from room temperature to -45 degrees C and then, at -10 degrees C/min down to -80 degrees C. After freezing, the cells were kept into mechanical freezers until the marrow infusion. To mobilize PBSC (peripheral blood stem cells), G-CSF (granulocyte colony stimulating factor) was given. RESULTS: A median of 3.16 x 10(8) cells/kg (range 0.86-24.22) of PBSC and 2.03 x 10(8) cells/kg (0.19-12.21) of bone marrow cells were frozen. The median time to reach granulocytes greater than 500/microL and platelets greater than 20,000/microL was 12 days (range 8-40) and 31 days (range 8-80), respectively. All patients had marrow engraftment after infusion of hematopoietic stem cells. CONCLUSION: The cryopreservation procedure using a controlled-rate freezer can store hematopoietic stem cells and potentially, cause less damage to the cells.


Subject(s)
Bone Marrow , Cryopreservation/methods , Stem Cells , Adolescent , Adult , Child , Child, Preschool , Female , Hematopoiesis , Humans , Male , Middle Aged
3.
Rev Hosp Clin Fac Med Sao Paulo ; 44(4): 167-70, 1989.
Article in Portuguese | MEDLINE | ID: mdl-2696069

ABSTRACT

Aplastic anemia is a condition characterized by bone marrow hipoplasia and pancytopenia. Various etiologic agents are related to the acquired form of this disease but in many cases the causative agents remain obscure. Severe aplastic anemia has been treated by immunosuppression and allogeneic marrow transplantation.


Subject(s)
Anemia, Aplastic/therapy , Bone Marrow Transplantation , Immunosuppression Therapy , Anemia, Aplastic/etiology , Anemia, Aplastic/immunology , Anemia, Aplastic/surgery , Humans
5.
Arq Gastroenterol ; 25 Spec No: 17-20, 1988.
Article in English | MEDLINE | ID: mdl-3060055

ABSTRACT

It is known that a confinement procedure will promote histological alterations in the gastric mucosa of rats. It is our hypothesis that, under these conditions, there should be an alteration in prostacyclin metabolism. Our findings corroborate this idea, which makes us suppose that the deficient release of prostacyclin-like activity by the rat's stomach may play an important role in gastric mucosa vitality and in its consequent damage.


Subject(s)
Epoprostenol/metabolism , Gastric Mucosa/metabolism , Restraint, Physical , Stress, Psychological/metabolism , Animals , Gastric Mucosa/pathology , Male , Platelet Aggregation , Rats
6.
Arq Gastroenterol ; 18(2): 54-9, 1981.
Article in Portuguese | MEDLINE | ID: mdl-7332500

ABSTRACT

The authors studied the effectiveness of the association of Nitrofurazone derivates with Polyethylene glycol (NPG) on peritoneal adhesions prevention. Despite the fact of constitutional characteristics may elicit or not the formation of adhesions and bands, they concluded that, although the drugs have not demonstrated the capacity of avoiding such phenomena, they could block this process at a fibrinous stage, which is relatively safe concerning the possibility of intestinal obstruction.


Subject(s)
Nitrofurazone/therapeutic use , Peritoneal Diseases/prevention & control , Polyethylene Glycols/therapeutic use , Tissue Adhesions/prevention & control , Animals , Dogs , Drug Therapy, Combination , Female , Male , Postoperative Complications/prevention & control
7.
Arq. gastroenterol ; 18(2): 54-9, 1981.
Article in Portuguese | LILACS | ID: lil-2918

ABSTRACT

Os autores estudaram em caes, a efetividade da associacao do derivado da nitrofurazona com o polietileno-glicol (NPG), na prevencao de aderencias peritoneais traumaticas (poscirurgicas). A partir dos resultados obtidos, concluem que, a despeito da constituicao do animal, como fator influenciador na capacidade de formacao de aderencias e bridas, a droga, de modo geral, mostrou-se capaz de prevenir o estabelecimento de aderencias fibrosas, bloqueando este processo evolutivo em um estagio fibrinoso, que nao acarreta maiores preocupacoes no que concerne a possibilidade de obstrucao intestinal


Subject(s)
Nitrofurazone , Peritoneum , Polyethylene Glycols
SELECTION OF CITATIONS
SEARCH DETAIL
...